LHC Group Continues Commitment to Clinical Quality With Addition of Tricia Nguyen as Chief Medical Officer

LHC Group, Inc. (NASDAQ: LHCG) announced today that Tricia Nguyen, MD, has joined the company as executive vice president and chief medical officer (CMO). Dr. Benjamin Doga, who had previously served part time in the role, will transition to lead medical director.

As a member of the executive leadership team and CMO, Dr. Nguyen is responsible for providing strategic leadership and serving as a medical expert for LHC Group. She will serve as the organization’s primary clinical advisor with shared accountability for advising strategic direction and overall revenue and earnings growth.

Dr. Nguyen was most recently a managing partner with Perla Health, a healthcare consulting firm. Previously, she served as senior vice president, Clinically Integrated Networks, and CEO, Commonwealth Health Network, for Inova Health Systems from April 2017 to September 2018. Her experience with other health systems includes senior leadership roles at Texas Health Resources (2013 – 2017), and at Banner Health Network (2011 – 2013).

Dr. Nguyen also has extensive experience in managed care, having served as vice president and CMO for BCBS of Kansas City (2010 – 2011), senior medical director, clinical operations, for BCBS of Florida – Jacksonville (2009 – 2010), and market medical officer and vice president for Humana (2005 – 2008). She also served as chair, Department of Emergency Medicine at Menorah Medical Center and as an emergency medicine physician at Independence Regional Health Center and Alegent Mercy Hospital (2000 – 2005).

Dr. Nguyen received her Bachelor of Science from Creighton University School of Pharmacy in 1992, her Doctor of Medicine from the University of Missouri at Columbia School of Medicine in 1996, and her Medical Management Executive MBA from the University of Texas at Dallas in 2005. She is board-certified in internal medicine, board-eligible in pediatrics, and a licensed doctor in Arizona and Texas.

Keith G. Myers, LHC Group’s chairman and chief executive officer, noted: “Since our founding 25 years ago, LHC Group has remained a clinically driven company that strives to be best in class in quality, efficiency, and patient satisfaction. Our senior leadership team is exceptionally deep and comprised of leading clinicians, operators, and healthcare professionals with a wealth of experience in in-home healthcare, hospitals and health systems, managed care, and state and federal government.

“Recruiting Dr. Nguyen to our team is in keeping with our clinical tradition, and a big win for our organization. She will be instrumental in working with us to accelerate the creation of clinically integrated networks, support our ongoing managed care initiatives, and ensure that our clinical quality and patient satisfaction measures continue leading the industry.”

About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations, providing quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group’s services cover a wide range of healthcare needs for patients and families dealing with illness, injury, or chronic conditions. The company’s 32,000 employees deliver home health, hospice, home and community based services, and facility-based care in 35 states and the District of Columbia – reaching 60 percent of the U.S. population aged 65 and older. LHC Group is the preferred in-home healthcare partner for 350 leading hospitals around the country. In 2019, the company was named to the inaugural Forbes list of “America’s Best-in-State Employers.”

Forward-looking StatementsCertain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by LHC Group’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and LHC Group undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in LHC Group’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well LHC Group’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Contacts:

Investor Relations						Media Relations
Eric Elliott						Mark Willis
Senior Vice President of Finance						Chief Communications Officer
(337) 233-1307						(337) 769-0673
Eric.Elliott@lhcgroup.com						Mark.Willis@lhcgroup.com